Clinical Trial Update: Serum Granulysin Level as a Marker to Detect the Severity of Psoriasis

View source ↗

Summary

The trial investigates whether serum granulysin level can serve as a biomarker to assess the severity of psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Snippet

Sponsor: Assiut University | Conditions: Psoriasis Vulgaris | Status: UNKNOWN